The global demand for Drug Repurposing Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.
Drug repurposing or drug repositioning, or therapeutic reprofiling refers to the process of identifying new uses for existing drugs that are already approved or undergoing clinical trials for different indications. Instead of developing entirely new drugs from scratch, this process focuses on finding alternative therapeutic applications for drugs that have already undergone safety testing and have known pharmacological profiles.
The need for cost-effective drug development is a major driver as drug repurposing offers an alternative approach that utilizes existing drugs that have already undergone safety testing, reducing time, cost, and risks associated with traditional drug development. The growing demand for effective treatments across various diseases and conditions also drives the market. It provides an avenue to explore new therapeutic options by identifying existing drugs that may have beneficial effects in different indications, addressing the significant unmet need for effective treatments. Advances in computational tools and data analysis techniques have significantly enhanced drug repurposing efforts. These tools enable researchers to analyze large datasets and identify potential drug-disease associations, facilitating efficient and systematic drug repurposing. The initiatives and collaborations among academia, industry, and government organizations promote knowledge sharing, facilitate data integration, and support collaborative research, leading to the identification of new repurposing opportunities. Regulatory support and expedited pathways have also played a role in driving the market. Regulatory agencies recognize its value and provide support through expedited approvals and designations for repurposed drugs, encouraging their development for unmet medical needs. Lastly, the increased focus on rare and neglected diseases has propelled drug repurposing efforts. Repurposing existing drugs for these indications offers a potential solution and has become a focus area for research.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug repurposing. The growth and trends of drug repurposing industry provide a holistic approach to this study.
This section of the drug repurposing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Therapeutic Area
This section covers the regional outlook, which accentuates current and future demand for the Drug Repurposing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the drug repurposing market include NuMedii Inc., Recursion Pharmaceuticals Inc., Biovista Inc., Exscientia Limited, Healx, Atomwise Inc., SOM Innovation Biotech S.L., Sosei Group Corporation (SoseiHeptares), Centene Corporation (Health Net LLC). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . DRUG REPURPOSING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Therapeutic Area
3.7.2 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY THERAPEUTIC AREA
5.1 Overview by Therapeutic Area
5.2 Historical and Forecast Data
5.3 Analysis by Therapeutic Area
5.4 Oncology Historic and Forecast Sales by Regions
5.5 CNS Disorders Historic and Forecast Sales by Regions
5.6 Neurodegenerative Diseases Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions
6 . GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY GEOGRAPHY
6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
6.3.1. Overview, Historic and Forecast Data Sales Analysis
6.3.2. North America By Segment Sales Analysis
6.3.3. North America By Country Sales Analysis
6.3.4. United State Sales Analysis
&n...
Avail customized purchase options to meet your exact research needs: